These novel medications , Semaglutide , represent a significant advancement in addressing metabolic dysfunction and possibly other ailments . They are classified as GLP-1 receptor agonists , meaning https://hassantbed790449.sharebyblog.com/41312851/retatrutide-a-deep-dive-into-glp-1-copyright